(0.51%) 5 214.08 points
(0.85%) 39 388 points
(0.27%) 16 346 points
(0.67%) $79.79
(1.39%) $2.33
(0.83%) $2 359.80
(0.81%) $28.60
(0.37%) $994.50
(0.07%) $0.928
(-0.07%) $10.86
(0.05%) $0.799
(0.17%) $92.70
3 days till quarter result
(bmo 2024-05-13)
Expected move: +/- 0.00%
@ $29.19
发出时间: 13 Feb 2024 @ 04:57
回报率: 13.77%
上一信号: Feb 12 - 22:41
上一信号:
回报率: -10.43 %
Live Chart Being Loaded With Signals
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease...
Stats | |
---|---|
今日成交量 | 30 956.00 |
平均成交量 | 136 811 |
市值 | 427.27M |
EPS | $0 ( 2024-05-06 ) |
下一个收益日期 | ( $-1.030 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0.106 (0.32%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-13 | Mcminn Rachel | Buy | 93 282 | Employee Stock Option (Right to buy) |
2024-03-13 | Cvijic Christine Mikail | Buy | 53 900 | Employee Stock Option (Right to buy) |
2024-03-13 | Cvijic Christine Mikail | Buy | 31 903 | Common Stock |
2024-03-13 | Cobb Stuart | Buy | 34 450 | Stock Option (Right to Buy) |
2024-03-13 | Cobb Stuart | Buy | 20 391 | Common Stock |
INSIDER POWER |
---|
100.00 |
Last 13 transactions |
Buy: 3 111 176 | Sell: 0 |
音量 相关性
Neurogene Inc. 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Neurogene Inc. 相关性 - 货币/商品
Neurogene Inc. 财务报表
Annual | 2023 |
营收: | $0 |
毛利润: | $-3.26M (0.00 %) |
EPS: | $-7.79 |
FY | 2023 |
营收: | $0 |
毛利润: | $-3.26M (0.00 %) |
EPS: | $-7.79 |
Financial Reports:
No articles found.
Neurogene Inc.
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。